$DNDN Recent Headlines Dendreon jumps on winning
Post# of 102231
Posted On: 12/17/2013 1:02:10 PM
$DNDN Recent Headlines
Dendreon jumps on winning European approval for prostate-cancer treatment 11:31 a.m. Sept. 17, 2013 - Russ Britt
Storm clouds getting darker for troubled Seattle biotech Dendreon 10:49 a.m. Aug. 23, 2013 - Russ Britt
Dendreon shares slump 16% on poor Provenge outlook 8:12 a.m. Aug. 9, 2013 - MarketWatch
In focus: Bears have another chance 8:09 p.m. Aug. 7, 2013 - Lawrence G. McMillan
As cancer drug sales struggle, Dendreon shares plunge 12:14 p.m. May 9, 2013 - Russ Britt
Analyst apologizes to clients for his call on Dendreon, stock climbs 12:00 p.m. March 7, 2013 - blogs.marketwatch.com
Four charts to watch 2:03 p.m. Feb. 7, 2013 - The Trading Deck
Synageva director bought shares for trust 1:41 p.m. Jan. 17, 2013 - Insider Monkey
Friday’s movers; Best Buy has best day in 4 years 4:47 p.m. Jan. 11, 2013 - Sue Chang
Bernstein lifts Dendreon price target to $10 7:34 a.m. Jan. 11, 2013 - Greg Morcroft
Dendreon upgraded to outperform by Bernstein 7:34 a.m. Jan. 11, 2013 - Greg Morcroft
Analyst downgrades rain on Dendreon 2:43 p.m. July 31, 2012 - Val Brickates Kennedy
Dendreon down 21% on earnings, restructuring news 9:27 a.m. July 31, 2012 - Val Brickates Kennedy
Updates, advisories and surprises 7:31 p.m. July 30, 2012 - MarketWatch
Seagate shares drop on earnings, outlook 5:33 p.m. July 30, 2012 - Wallace Witkowski
Dendreon to slash jobs amid tepid earnings 5:12 p.m. July 30, 2012 - Val Brickates Kennedy
Dendreon shares drop 18% after being unhalted 5:10 p.m. July 30, 2012 - Wallace Witkowski
Dendreon to restructure, slash 600 jobs 3:31 p.m. July 30, 2012 - Val Brickates Kennedy
Dendreon shares halted for news pending 3:13 p.m. July 30, 2012 - Laura Mandaro
Savient to slash workforce by 35% 11:08 a.m. July 9, 2012 - MarketWatch.com
The Worst Biotech CEO of 2013 Is... 7:58 a.m. Today - TheStreet.com
Interesting DNDN Put And Call Options For January 2014 11:13 a.m. Dec. 12, 2013 - TheStreet.com
Your Vote Counts: Who is the Worst Biotech CEO of 2013? 8:32 a.m. Dec. 12, 2013 - TheStreet.com
Dendreon: Where Things Stand Now 5:21 a.m. Dec. 9, 2013 - Seeking Alpha
DNDN January 2014 Options Begin Trading 10:53 a.m. Nov. 27, 2013 - TheStreet.com
Dendreon Has Hidden Value For The Right Buyer 2:04 p.m. Nov. 25, 2013 - Seeking Alpha
DNDN December 27th Options Begin Trading 10:56 a.m. Nov. 21, 2013 - TheStreet.com
Dendreon (DNDN) Highlighted As Today's Perilous Reversal Stock 3:33 p.m. Nov. 20, 2013 - TheStreet.com
Dendreon (DNDN) in Focus: Stock Moves 9.7% Higher - Tale of the Tape 8:30 a.m. Nov. 20, 2013 - Zacks.com
Investments On Biotech's Cutting Edge: Joseph Pantginis 4:41 p.m. Nov. 18, 2013 - Seeking Alpha
The Immunotherapy Company You Never Saw Coming: Advaxis CSO Interview 12:48 p.m. Nov. 17, 2013 - Seeking Alpha
Dendreon Narrows Loss, Provenge Disappoints Again - Analyst Blog 9:50 a.m. Nov. 15, 2013 - Zacks.com
Dendreon: A Classic Plan Of Desperation 2:38 p.m. Nov. 13, 2013 - Seeking Alpha
Dendreon's Earnings Review 10:47 a.m. Nov. 13, 2013 - Seeking Alpha
Dendreon Has Another Disaster Quarter 9:02 a.m. Nov. 13, 2013 - Seeking Alpha
Combination Therapies Hold Key To Future Cancer Treatments 2:32 p.m. Nov. 12, 2013 - Seeking Alpha
Dendreon Corporation CEO Discusses Q3 2013 Results - Earnings Call Transcript 11:59 a.m. Nov. 12, 2013 - Seeking Alpha
Dendreon Restructuring Aims to Thwart Weak Provenge Sales 9:35 a.m. Nov. 12, 2013 - 247WallSt.com
Dendreon Earnings Suck, But Still Send DNDN Stock Higher 3:40 a.m. Nov. 12, 2013 - InvestorPlace.com
Earnings Season Is Not Over: D.R. Horton, Dendreon, Dean Foods And Health Management Associates 10:20 a.m. Nov. 11, 2013 - Seeking Alpha
Clinical Studies Updates, and Stock Price Movements - Research Report on Merck, Select Medical Holdings, Galena Biopharma, Dendreon, and Echo Therapeutics 8:00 a.m. Dec. 16, 2013 - PR Newswire
Market Data Ahead of the Bell: Dendreon, Stryker, Novartis, and Repros Therapeutics 8:00 a.m. Dec. 16, 2013 - PR Newswire
RBCC Appoints New CEO to Achieve Regenerative Medicine Goals 5:00 a.m. Dec. 5, 2013 - BusinessWire
Dendreon Announces Webcast Presentation at Deutsche Bank BioFEST Conference 4:01 p.m. Nov. 26, 2013 - BusinessWire
Settlement Agreement, Presentation of Trial Results, and Stock Price Update - Research Report on Johnson & Johnson, Mettler-Toledo, Galena Biopharma, Dendreon, and Amedisys 8:00 a.m. Nov. 25, 2013 - PR Newswire
NanoString Technologies Names David W. Ghesquiere Senior Vice President, Corporate & Business Development 4:05 p.m. Nov. 20, 2013 - BusinessWire
Marketing Authorizations, Financial Results, Public Offering and Leadership Transitions - Research Report on Regeneron, Dendreon, Dyax, Techne, and ICU Medical 8:04 a.m. Nov. 15, 2013 - PR Newswire
StemCells, Inc. Appoints Greg Schiffman as Chief Financial Officer 9:00 a.m. Nov. 14, 2013 - GlobeNewswire
Under AAAResearchReports.com Microscope: Repros Therapeutics Inc., Dendreon Corp., Novartis AG, and Stryker Corp. 8:10 a.m. Nov. 13, 2013 - PR Newswire
ARIA, DNDN, HSOL and OREX added to NASDAQ Active Stock Watch List at EPR 9:29 a.m. Nov. 12, 2013 - ACCESSWIRE
Dendreon Announces Third Quarter 2013 Results 8:00 a.m. Nov. 12, 2013 - BusinessWire
RBCC Explores Promising New Breakthroughs in Regenerative Medicine 6:46 a.m. Nov. 5, 2013 - BusinessWire
SNTA, DNDN, ZGNX and NVGN added to NASDAQ Active Stock Watch List at EPR 9:58 a.m. Oct. 28, 2013 - ACCESSWIRE
Market Briefing: Emerging Growth NASDAQ Stocks in the News 3:22 p.m. Oct. 25, 2013 - PR Newswire
Early Briefing and Review: Dendreon Corp., Stryker Corp., Novartis AG, and Repros Therapeutics Inc. 8:00 a.m. Oct. 22, 2013 - PR Newswire
Quarterly Reports, Licensing Agreements, and Clinical Data - Research Report on Theravance, Dendreon, ImmunoGen, Compugen, and Acorda 8:00 a.m. Oct. 22, 2013 - PR Newswire
Mentor Capital Cancer Immunotherapy Index Up 100% in 2013 8:03 a.m. Oct. 16, 2013 - BusinessWire
Dendreon to Host Conference Call on November 12 to Announce Third Quarter Financial Results 4:30 p.m. Oct. 7, 2013 - BusinessWire
Dendreon Corporation Announces Presentation of PROVENGE(R) (sipuleucel-T) Data at the 2013 European Cancer Congress 7:30 a.m. Sept. 27, 2013 - BusinessWire
Pre-Market Review: Dendreon Corp., Stryker Corp., Novartis AG, and Repros Therapeutics Inc. 8:49 a.m. Sept. 25, 2013 - PR Newswire
Dendreon jumps on winning European approval for prostate-cancer treatment 11:31 a.m. Sept. 17, 2013 - Russ Britt
Storm clouds getting darker for troubled Seattle biotech Dendreon 10:49 a.m. Aug. 23, 2013 - Russ Britt
Dendreon shares slump 16% on poor Provenge outlook 8:12 a.m. Aug. 9, 2013 - MarketWatch
In focus: Bears have another chance 8:09 p.m. Aug. 7, 2013 - Lawrence G. McMillan
As cancer drug sales struggle, Dendreon shares plunge 12:14 p.m. May 9, 2013 - Russ Britt
Analyst apologizes to clients for his call on Dendreon, stock climbs 12:00 p.m. March 7, 2013 - blogs.marketwatch.com
Four charts to watch 2:03 p.m. Feb. 7, 2013 - The Trading Deck
Synageva director bought shares for trust 1:41 p.m. Jan. 17, 2013 - Insider Monkey
Friday’s movers; Best Buy has best day in 4 years 4:47 p.m. Jan. 11, 2013 - Sue Chang
Bernstein lifts Dendreon price target to $10 7:34 a.m. Jan. 11, 2013 - Greg Morcroft
Dendreon upgraded to outperform by Bernstein 7:34 a.m. Jan. 11, 2013 - Greg Morcroft
Analyst downgrades rain on Dendreon 2:43 p.m. July 31, 2012 - Val Brickates Kennedy
Dendreon down 21% on earnings, restructuring news 9:27 a.m. July 31, 2012 - Val Brickates Kennedy
Updates, advisories and surprises 7:31 p.m. July 30, 2012 - MarketWatch
Seagate shares drop on earnings, outlook 5:33 p.m. July 30, 2012 - Wallace Witkowski
Dendreon to slash jobs amid tepid earnings 5:12 p.m. July 30, 2012 - Val Brickates Kennedy
Dendreon shares drop 18% after being unhalted 5:10 p.m. July 30, 2012 - Wallace Witkowski
Dendreon to restructure, slash 600 jobs 3:31 p.m. July 30, 2012 - Val Brickates Kennedy
Dendreon shares halted for news pending 3:13 p.m. July 30, 2012 - Laura Mandaro
Savient to slash workforce by 35% 11:08 a.m. July 9, 2012 - MarketWatch.com
The Worst Biotech CEO of 2013 Is... 7:58 a.m. Today - TheStreet.com
Interesting DNDN Put And Call Options For January 2014 11:13 a.m. Dec. 12, 2013 - TheStreet.com
Your Vote Counts: Who is the Worst Biotech CEO of 2013? 8:32 a.m. Dec. 12, 2013 - TheStreet.com
Dendreon: Where Things Stand Now 5:21 a.m. Dec. 9, 2013 - Seeking Alpha
DNDN January 2014 Options Begin Trading 10:53 a.m. Nov. 27, 2013 - TheStreet.com
Dendreon Has Hidden Value For The Right Buyer 2:04 p.m. Nov. 25, 2013 - Seeking Alpha
DNDN December 27th Options Begin Trading 10:56 a.m. Nov. 21, 2013 - TheStreet.com
Dendreon (DNDN) Highlighted As Today's Perilous Reversal Stock 3:33 p.m. Nov. 20, 2013 - TheStreet.com
Dendreon (DNDN) in Focus: Stock Moves 9.7% Higher - Tale of the Tape 8:30 a.m. Nov. 20, 2013 - Zacks.com
Investments On Biotech's Cutting Edge: Joseph Pantginis 4:41 p.m. Nov. 18, 2013 - Seeking Alpha
The Immunotherapy Company You Never Saw Coming: Advaxis CSO Interview 12:48 p.m. Nov. 17, 2013 - Seeking Alpha
Dendreon Narrows Loss, Provenge Disappoints Again - Analyst Blog 9:50 a.m. Nov. 15, 2013 - Zacks.com
Dendreon: A Classic Plan Of Desperation 2:38 p.m. Nov. 13, 2013 - Seeking Alpha
Dendreon's Earnings Review 10:47 a.m. Nov. 13, 2013 - Seeking Alpha
Dendreon Has Another Disaster Quarter 9:02 a.m. Nov. 13, 2013 - Seeking Alpha
Combination Therapies Hold Key To Future Cancer Treatments 2:32 p.m. Nov. 12, 2013 - Seeking Alpha
Dendreon Corporation CEO Discusses Q3 2013 Results - Earnings Call Transcript 11:59 a.m. Nov. 12, 2013 - Seeking Alpha
Dendreon Restructuring Aims to Thwart Weak Provenge Sales 9:35 a.m. Nov. 12, 2013 - 247WallSt.com
Dendreon Earnings Suck, But Still Send DNDN Stock Higher 3:40 a.m. Nov. 12, 2013 - InvestorPlace.com
Earnings Season Is Not Over: D.R. Horton, Dendreon, Dean Foods And Health Management Associates 10:20 a.m. Nov. 11, 2013 - Seeking Alpha
Clinical Studies Updates, and Stock Price Movements - Research Report on Merck, Select Medical Holdings, Galena Biopharma, Dendreon, and Echo Therapeutics 8:00 a.m. Dec. 16, 2013 - PR Newswire
Market Data Ahead of the Bell: Dendreon, Stryker, Novartis, and Repros Therapeutics 8:00 a.m. Dec. 16, 2013 - PR Newswire
RBCC Appoints New CEO to Achieve Regenerative Medicine Goals 5:00 a.m. Dec. 5, 2013 - BusinessWire
Dendreon Announces Webcast Presentation at Deutsche Bank BioFEST Conference 4:01 p.m. Nov. 26, 2013 - BusinessWire
Settlement Agreement, Presentation of Trial Results, and Stock Price Update - Research Report on Johnson & Johnson, Mettler-Toledo, Galena Biopharma, Dendreon, and Amedisys 8:00 a.m. Nov. 25, 2013 - PR Newswire
NanoString Technologies Names David W. Ghesquiere Senior Vice President, Corporate & Business Development 4:05 p.m. Nov. 20, 2013 - BusinessWire
Marketing Authorizations, Financial Results, Public Offering and Leadership Transitions - Research Report on Regeneron, Dendreon, Dyax, Techne, and ICU Medical 8:04 a.m. Nov. 15, 2013 - PR Newswire
StemCells, Inc. Appoints Greg Schiffman as Chief Financial Officer 9:00 a.m. Nov. 14, 2013 - GlobeNewswire
Under AAAResearchReports.com Microscope: Repros Therapeutics Inc., Dendreon Corp., Novartis AG, and Stryker Corp. 8:10 a.m. Nov. 13, 2013 - PR Newswire
ARIA, DNDN, HSOL and OREX added to NASDAQ Active Stock Watch List at EPR 9:29 a.m. Nov. 12, 2013 - ACCESSWIRE
Dendreon Announces Third Quarter 2013 Results 8:00 a.m. Nov. 12, 2013 - BusinessWire
RBCC Explores Promising New Breakthroughs in Regenerative Medicine 6:46 a.m. Nov. 5, 2013 - BusinessWire
SNTA, DNDN, ZGNX and NVGN added to NASDAQ Active Stock Watch List at EPR 9:58 a.m. Oct. 28, 2013 - ACCESSWIRE
Market Briefing: Emerging Growth NASDAQ Stocks in the News 3:22 p.m. Oct. 25, 2013 - PR Newswire
Early Briefing and Review: Dendreon Corp., Stryker Corp., Novartis AG, and Repros Therapeutics Inc. 8:00 a.m. Oct. 22, 2013 - PR Newswire
Quarterly Reports, Licensing Agreements, and Clinical Data - Research Report on Theravance, Dendreon, ImmunoGen, Compugen, and Acorda 8:00 a.m. Oct. 22, 2013 - PR Newswire
Mentor Capital Cancer Immunotherapy Index Up 100% in 2013 8:03 a.m. Oct. 16, 2013 - BusinessWire
Dendreon to Host Conference Call on November 12 to Announce Third Quarter Financial Results 4:30 p.m. Oct. 7, 2013 - BusinessWire
Dendreon Corporation Announces Presentation of PROVENGE(R) (sipuleucel-T) Data at the 2013 European Cancer Congress 7:30 a.m. Sept. 27, 2013 - BusinessWire
Pre-Market Review: Dendreon Corp., Stryker Corp., Novartis AG, and Repros Therapeutics Inc. 8:49 a.m. Sept. 25, 2013 - PR Newswire
(0)
(0)Scroll down for more posts ▼